Background. Patients with rheumatoid arthritis (RA) should be treated in close cooperation between GPs and rheumatologists and following treatment guidelines. In this study, we analyse the utilization of health care among patients with RA and explain the determinants of the frequency of use of GP and rheumatologist services. Methods. A random sample (n = 1259) of adult Estonian patients with RA was investigated in 2007. A pre-structured questionnaire included questions regarding respondents' socio-economic status, quality of life, self-reported use of health care, time, distance and financial aspects of access to health care. The impact of the variables on the frequency of use of health care was analysed with regression analysis. Results. Use of GP services was higher among people who lived outside the capital, had more health problems and experienced disability due to their RA. Time and distance limits had an effect on the frequency of use of both primary and specialist care. A shorter waiting time to the GP and a longer waiting time to the rheumatologist were associated with more frequent use of GP services, but a shorter waiting time to the rheumatologist was related to more frequent visits to the rheumatologist. Patient's costs were not associated with the frequency of health care use. Conclusions. Use of health care among people with RA depends primarily upon doctors' waiting times, patients' place of residence and their health status. The GP has a significant role in the management of RA patients, especially for those who have multiple health problems and those living in rural areas.
Introduction
Rheumatoid arthritis (RA) as a chronic and progressive disease is an important cause of disability and morbidity. Guidelines recommend early treatment of RA patients with disease-modifying antirheumatic drugs and the continued involvement of a rheumatologist to assess response to treatment and review the treatment plan. 1 In countries where GPs have a gatekeeper role, the GP is usually the first contact for patients with RA. GPs are expected to evaluate the patient and make a decision about referring their patients to specialists. 2, 3 RA outcomes would be optimized by interdisciplinary care, whereby both GPs and rheumatologists play important roles, including the optimal use of resources. 2, 4 There are no standards for patients with respect to the regularity of visits to the GP; however, there is a consensus that the frequency of visits to the rheumatologist should depend on the level of activity of RA. 5 It has been reported that the utilization of health services both in primary care and at the specialist level could be determined by the patient's health status as well as by the level of accessibility to health care. 4, [6] [7] [8] [9] [10] In Estonia, access to rheumatologist care for RA patients is quite good compared to some other countries. For example, Germany still has less than half of the suggested two rheumatologists per 100 000 people and access for new patients is limited due to long waiting times. 10 In Canada, only 26% of RA patients visited a rheumatologist at least once per year and 64% were treated only by their GPs. 11 In Estonia, the number of GPs and rheumatologists per 100 000 inhabitants in 2008 was 62.1 and 2.4, respectively.
12 By population, the distribution of GP practices is similar throughout the country, but rheumatology care is mostly aggregated in two centres-in the capital, Tallinn, and in Tartu-though outpatient rheumatologist services are also available in other towns. Visits to the GP are free for insured patients (95% of the population is covered by national health insurance), but there is a fee for outpatient specialist visits (up to V3.20 per visit). According to waiting list standards in 2007, GPs had to be able to see a patient with a chronic illness within three working days after an appointment request; waiting time for an outpatient specialist could not exceed 4 weeks after referral. 13 Most of the time health care providers follow these waiting list standards. 7, 9, [14] [15] [16] The management of patients with RA in Estonia is divided between rheumatologists and GPs. As GPs serve a gate-keeping function, patients first need referrals from their GPs to see the rheumatologist in order to confirm the diagnosis and begin the proper treatment. It is recommended that every RA patient see the rheumatologist at least two times per year to assess the patient's status and review treatment. 17 If the patient already has a persistent functional impairment due to disease, which leads to restrictions in their everyday life, the patient's disability status will be confirmed by the national committee on disability expertise, which includes medical and social welfare experts.
Previously, we showed that people with chronic conditions visit their GPs more frequently than they visit specialists. 16 Until now, there has been no data regarding how often Estonian RA patients visit their GPs and rheumatologists and which factors may have an influence on the use of different kind of services.
Thus, in this study, we analyse the utilization of health care among patients with RA and explain the predictors of the frequency of use of GP and rheumatologist services.
Methods

Study sample
Between October 2007 and January 2008, we conducted a postal survey in partnership with the Estonian Health Insurance Fund (EHIF) among adult patients with RA to assess the use of and access to health care as well as their satisfaction with the care provided. Two thousand patients were randomly selected from the EHIF database (n = 8814). Inclusion criteria were (i) patients had to be at least 18 years old; (ii) patients have been diagnosed with RA (M05 or M06 according to International Classification of Disease, Tenth Revision, confirmed by the rheumatologist) and (iii) patients have had at least one contact episode with health care providers over the past 12 months. All patients gave written and informed consent. The EHIF database does not include information about the patient's native language, so all respondents received the questionnaire in both Estonian and Russian. A reminder letter with a new questionnaire was sent to all non-respondents 4 weeks later. The questionnaires were sent out, collected and coded by an EHIF representative, and the information was passed on to the researchers in an anonymous form due to data protection requirements.
The response rate of the study was 63%. Nonrespondents were younger than respondents, but the two groups did not differ in gender. The structure of the total study population (all RA patients in 2006 in the EHIF database, n = 8814), sample (n = 2000), respondents (n = 1259) and non-respondents (n = 741) by gender and age is presented in Table 1 .
Questionnaire
This study forms part of the RA patient survey entitled 'Quality of life: Coping with illness and satisfaction with access to health services'. The original prestructured questionnaire included 48 questions and subquestions, including 96 variables. The data set used in this study was as follows: (i) socio-economic variables (age, gender, education, employment status, average net income per household member per month and place of residence); (ii) self-reported use of health care (out-of-pocket costs for transportation to the GP and rheumatologist as well as the fee for the rheumatologist's visit) and (iii) access to health care. Use of health care was assessed with the question: 'During the past 12 months, have you, because of your RA, visited your GP or rheumatologist, and if so, how many times?' Access to health care was evaluated by the self-reported length of waiting times to see the GP and rheumatologist. Additionally, patients evaluated the time and money spent on seeing the GP and rheumatologist, as an indicator of possible barriers to accessing health care.
For further analysis, the respondents were divided into three age groups: <49 years, 50-74 years and >75 years. The respondents were divided into two groups according to income: (i) median income (V223.60) and below and (ii) above the median. Educational status 18 Disease history was measured by the self-reported duration of the disease, the co-morbidity and disability status. The co-morbidity and disability status were assessed with the questions 'Do you have any other permanent or chronic illness in addition to RA?' and 'Has your disability status due to RA been confirmed by the national committee on disability expertise?' The answer options were 'yes' and 'no'.
Statistical analysis
The characteristics of the study population were initially described using frequency distributions and summary statistics. Differences between the less and more frequent health care users were described as unadjusted odds ratios (ORs) with 95% confidence intervals. The threshold for high use of GP and rheumatologist services was the median value (two times per year) of the self-reported number of visits calculated for all RA patients (1 < median, 2 > median). The Spearman correlation coefficient was used to estimate relationships between variables, and binary logistic regression was used to calculate the associations between the independent variables and health care use. The independent variables were chosen as follows: socio-economic variables (age, gender, education, place of residence, income and employment status), disease characteristics (duration of RA, co-morbidity and disability status due to RA), access to health care (waiting time as well as time and money spent to see doctors) and dimensions of QoL. The models include categories of statistically significant exposure variable with ORs, except for time and dimensions of QoL, which have been calculated with exposure as a continuous variable and the ORs with one unit decreases in those variables. The level of statistical significance was set at P <0.05 throughout. All statistically non-significant variables were excluded from the final models. Data were analysed using SPSS 15.0 statistical software for Windows.
Results
Characteristics of study sample Of the respondents, 17.6% were male and 82.4% were female. The mean respondent age was 59.2 (SD = 13.1) years (ages ranged from 19 to 93 years); 79% were >50 years of age. Almost one quarter (23%) of the respondents lived in the capital, 38.5% in other urban areas and 38.5% lived in rural areas. The education distribution of the respondents showed that 21% had a primary school education (up to 9 years), 61% had a secondary school education (10 or 12 years) and 18% had a university education. Less than half of the respondents (43%) were employed and 57% were retired or unemployed. The average monthly net income per household member reported by the study patients was V279.40 (SD = V141.24). Older patients and patients living in rural areas were more likely to be unemployed, less educated and have lower income. Despite these factors, there was no association between a respondent's age and his or her place of residence.
Disease characteristics and QoL
The mean duration of RA was 11.6 (SD = 11.5) years (median 7; range 0-63 years) and correlated with the patient's age (q = 0.23, P < 0.0001). Forty-five percent of respondents were disabled due to RA, and almost two-thirds (64%) had another concurrent chronic condition. Eight dimensions were used to describe the patients' QoL, with the means (SD) reported as follows: (24.54 ). All QoL dimensions were rated lower by older respondents (P < 0.001) and respondents with longer disease duration (P < 0.05).
Self-reported direct costs
The average amount of self-reported costs of care for RA patients per month was V19.50 (SD = V33.30), which was, on average, 7% of the patients' average monthly income. The average transportation cost per visit was V2.50 (range from V0.30 to V22.40) to see the GP and V6.60 (range from V0.30 to V95.80) to see the rheumatologist. The average amount of user fees paid to see the rheumatologist was V15.30 (range from V1.60 to V383.40) per year. The average amount of time spent on consulting (including travel and visiting time) was 1.75 (SD = 1.2) hours with the GP and 3.5 (SD = 3.4) hours with the rheumatologist over the 12-month period.
Use of and access to health services During the past 12 months, about three quarters of the patients visited their GP and rheumatologist, 74% and 73%, respectively; of all respondents, 15% visited only the GP, 15% only the rheumatologist, 59% of the respondents visited the GP as well as rheumatologist and 11% had contacts with other health service providers (they were in hospital or received rehabilitation services). The average self-reported number of visits to the GP was 4.65 (SD = 3.99) and 3.54 (SD = 2.81) to the rheumatologist (P < 0.001). The waiting time to see a GP was as follows: 25% of respondents received an appointment on the same day, 33% during 1-2 days, Family Practice-an international journal 22% during 3-4 days and 20% had to wait >5 days. The waiting time for rheumatologists was up to 1 week for 20% of the respondents, 1-2 weeks for 20% and 3-4 weeks for 26%. For 34% of respondents, the waiting time to see a rheumatologist was >1 month.
Determinants of health care utilization
Associations between the characteristics of the patients and frequency of visits to the GP and rheumatologist are shown in Tables 2 and 3 . When calculating the adjusted ORs for all variables which were significantly associated with more frequent use of GP and rheumatologist services we found that all together, eight factors determined use of GP services by people with RA and four factors determined use of rheumatologist services (Tables 2 and 3 ). Regression analysis showed that use of GP services was higher among disabled patients outside the capital, those with concurrent chronic diseases and those with lower QoL scores (role limitations due to physical health and general health). Lower levels of physical function associated with fewer visits to the rheumatologist. Limits involving time and distance also had an effect on the frequency of visits: a shorter waiting time to the GP and a longer waiting time to the rheumatologist determined more frequent use of GP services. At the same time, a shorter waiting time for the rheumatologist was associated with more frequent visits to the rheumatologist, irrespective of the waiting time to see the GP. Longer travel times were related to less frequent use of rheumatologist services, but more frequent visits to the GP. Financial matters, such as costs related to visits and transportation, were not found to be associated with the frequency of use of either GP or rheumatologist services.
Discussion
In general, RA patients used GP services more frequently than rheumatologist services, especially in rural areas. Vilhjalmsson 8 also found that closer proximity to the patients' place of residence increases a GP's accessibility in comparison to specialists. The frequency of visits to GPs and rheumatologists was determined by a number of factors. One important factor was the waiting time to see a doctor, which also has been reported to reduce access to health care. 8, 9 Shorter waiting times for the GP and longer ones for the rheumatologist were associated with more frequent use of GP services. Simultaneously, easier access to the rheumatologist is linked with more frequent use of rheumatologist services, independent of the waiting time for the GP. As demonstrated earlier, in rural areas, people prefer the GP to be their first contact with the health system, 9,15 and the same principle applies to RA patients. One reason for more frequent visits to the GP is also the shorter distance to travel to the GP in comparison with the specialist. This is particularly important for people, who have more than one health problem, but also for rural people. 6, 8 Furthermore, impaired physical function determined less use of outpatient health care since this amplifies the distance barriers that need to be overcome. On the other hand, in the capital, it may take as much time to travel to a specialist as to the GP, which may explain why these patients accessed more rheumatology services. Concurrently, as previously demonstrated, waiting times for GPs are significantly longer in the capital than in the rest of the country. 14, 15 It has been reported previously that co-payments for health services may restrict access to care, 19 and out-of-pocket expenditure associated with RA may cause a considerable economic burden for those patients. 20 However, as resulted from our study, patients' self-reported expenditure did not affect the frequency of their visits to doctors. It might be related to the fact that out-of-pocket expenditure related to the travel and fees for visits comprises a rather small part of RA patients' income, and therefore, the other factors play more important roles in access to care. This study used the EHIF database of RA patients who already had RA diagnoses confirmed by the rheumatologist. Because Estonia does not have an RA registry, it was not possible to access the patients' medical records at their GPs' offices across Estonia to look for the disease activity, medication and other clinical characteristics. As reported previously, more severe disease activity determines the higher utilization of care. 21, 22 Therefore, missing data about disease activity can be considered as a limitation of this study.
Our study has relied on the self-reported data, which can, of course, have some bias; this is also a possible limitation of this study. There remains a question about the possible recall bias of patients' self-reported use of health care. It is possible that, due to the 12-month time frame, the use of health care and frequency of the visits could be under-reported, especially among the older patients; several studies have found such an association. 23 As our sample of respondents slightly over-represented, the older population and older respondents tended to report less frequent use of both GP's and specialist's services the possible under-reporting of the visits exists in our study, too. On the other side, the respondents may recall something they feel is important and that they want to convey regardless of whether it took place within the specified time frame. Because of this 'telescoping' effect, the overestimation of the actual consultation frequency may exist in our study as well. 24 However, the self-reported number of visits was associated with other variables, such as the patients' health status, place of residence and access to the health services. Other studies have also identified these factors. 5, 6, 8, 9, 14, 15 These matters support the validity of the results.
As recommended in RA guidelines, the early treatment of RA patients should start with the diagnosis of RA and the rheumatologist should assess the response to treatment and review the treatment plan. 1 The study found that more frequent visits to the rheumatologist were associated with younger patient age. The older patients with longer course of disease tended to visit the rheumatologist less frequently than patients with short course of disease. Thus, the role of the rheumatologist seems to be most important in the early stages of the disease. If a remission has been achieved, the patient may not need to see the rheumatologist so often and treatment could be monitored by the GP as well. As has been found previously, 16, 22 older patients mostly have multiple chronic conditions and for that reason, the role of GPs in the management of older RA patients would be more important. Nevertheless, RA treatment guidelines recommend that RA patients see their rheumatologist at least twice a year in order to assess response to treatment and review the treatment plan. 17 Although less frequent use of rheumatologist care is associated with several factors, GPs who see these patients more frequently should encourage their RA patients to visit their rheumatologist regularly as well.
Conclusions
Use of GP and rheumatologist services among the Estonian RA population depends primarily upon doctors' waiting times, patients' place of residence and their health status. In general, GP services were used more frequently than the rheumatologist services. As resulted from our study, the more frequent use of GP services was associated with three groups of factors: (i) factors related to the patient's health status; (ii) distance factors (place of residence, time spent to see doctors) and (iii) organizational aspects of health care delivery related to the waiting times. Thus, besides the rheumatologist, the role of GPs in the management of RA cannot be underestimated, especially for older patients who have multiple health problems and those living in rural areas.
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